A population-based analysis to determine the impact of the 13-valent pneumococcal conjugate vaccine on community-acquired pneumonia in British Columbia, Canada

Nav

General Info

Geography

British Columbia

Canada (CAN)

Coverage type

Subnational

Time period covered

01/2000 - 12/2018

Data type

Scientific literature

Keywords

Lower respiratory infections

Citation

Authors

Vadlamudi NK, Patrick DM, Rose C, Sadatsafavi M, Hoang L, Marra F

Journal

Vaccine

Volume

Issue

Pages

1047-1053

Publication year

2022

Suggested citation

Vadlamudi NK, Patrick DM, Rose C, Sadatsafavi M, Hoang L, Marra F. A population-based analysis to determine the impact of the 13-valent pneumococcal conjugate vaccine on community-acquired pneumonia in British Columbia, Canada. Vaccine. 2022; 40(7): 1047-1053.

DOI

101016jvaccine202112065

PMID

35012778

GHDx Entry last modified on: Mar 22, 2024

Header sites

Search form

Main menu

A population-based analysis to determine the impact of the 13-valent pneumococcal conjugate vaccine on community-acquired pneumonia in British Columbia, Canada

Nav